Self-pay: Process and pipeline
Paying attention to the different stages in the self-pay journey can help ensure a healthy pipeline, explains independent consultant Richard Gregory
Following on from last...
Occupational health sector hit by changes in working practices, says HML
Covid-19 has created an ‘extremely challenging’ environment for the occupational health sector, one of its leading providers, Health Management Limited (HML), has said after...
Time to grow
As demand for private healthcare is sustained, LaingBuisson’s Private Acute Healthcare Conference heard how operators are seizing the opportunities for expansion across all areas...
UAE: Okadoc launches healthcare app
Healthcare technology company Okadoc has launched its telemedicine healthcare app across the UAE. The Dubai-based company fast-tracked the release in response to what it...
Transform offers student placements at Midlands site
Transform Hospital Group has partnered with Birmingham City University to offer student placements at its Bromsgrove hospital.
Under the collaboration, up to seven students on the...
High performance data in the healthcare sector
In the latest column from the Private Healthcare Information Network (PHIN), CEO Ian Gargan explains the rationale behind its recent Quality Forum, focused on...
Potential increase in future demand but Spire says outlook remains uncertain
Spire Healthcare has said it is unable to provide market guidance for FY20 as the Covid-19 pandemic continues to create ‘significant uncertainty’.
Commenting on the...
Japan: Nipro inks Japan healthcare’s first sustainability-linked loan
Green bonds have become a mainstay of financing in Japan, but the sustainability-linked loan market has been much slower to take off there. It...
HMi meets… Sangita Reddy
The joint managing director of Apollo Hospitals talks about the relationship between private healthcare and the government, and her priorities for the post-Covid-19 world
Sangita...
Sweden: Eir Ventures I life sciences VC fund closes at €122.3m
Eir Ventures, a Nordic Life Science Venture Capital manager, has closed Eir Ventures I at €122.3m (US$137.8m) . The fund is the firm’s first...
©2024 All rights reserved LaingBuisson 